Journey Mexico’s Statement on US Requirements for COVID-19 Tests for All International Travelers

Journey Mexico is aware of the new requirement for all passengers bound to the United States, including visitors, residents, and US citizens above the age of 2 years old, to show proof of a Negative Viral Test (PCR and Antigen Test NOT Antibody test) within 72 hours of their departure from Mexico. According to the information available at this time, the regulation will take effect on January 26th and requires paper or electronic proof, which will need to be presented at the departure airport within Mexico prior to boarding. Those who have tested positive for the virus within the past three months before travel can bypass the test requirement if they bring proof that they have recovered from the virus and are cleared to travel by a licensed healthcare provider or health official.

For all guests who have booked accommodation through Journey Mexico, we will collaborate with our guests’ hotels, villas, and resorts for to facilitate these tests prior to departure. As a guideline, and subject to exceptions and change, tests generally cost between $150-$300 USD and guests will need to go to a testing facility where the test will be administered. In-hotel / villa testing is also possible in most (but not all) destinations subject to availability and additional cost. Results are typically available 24-72 hours after samples have been taken, but can take longer depending on the volume at the time of testing.

In the event that a guest tests positive and is unable to return home, Journey Mexico will work closely with guests, travel advisors, suppliers, and health facilities to organize the best possible care and services on a case by case basis. We know these are challenging times for travelers and the travel industry and will continue to do everything in our power to exceed your expectations and assist in the best possible travel experience possible.

Strong, Optimistic, and Compassionate regards,

Zachary Rabinor
Founder | President | CEO